Last week, Gil Kerlikowske, Director of the White House Office of National Drug Control Policy spoke before the Inter-American Drug Abuse Control Commission. As expected, he touted the effectiveness of the newly unveiled “Third Way” strategy that the U.S. government is currently promoting. He framed the third-way as the “middle ground approach to drug policy” between legalization and regulation of